News & Updates

Show Multimedia Only

Sotrovimab of no help in attenuating COVID-19 severity in face of Omicron BA.2 subvariant

26 Sep 2022

Treatment with sotrovimab does not appear to confer protection against severe forms of COVID-19 in a setting dominated by the Omicron BA.2 subvariant, a study has found.

26 Sep 2022

Play-based exercise boosts fitness, fundamental movement in kids with bronchiectasis

23 Sep 2022 by

Children suffering from bronchiectasis may benefit from a play-based therapeutic exercise regimen, which results in better fitness and fundamental movement skill (FMS), according to a recent pilot trial.

23 Sep 2022

DANFLU-1: High-dose quadrivalent flu vax reduces hospitalization, death in older adults

22 Sep 2022 by

Older adults who receive a high-dose quadrivalent influenza vaccine have a 49 percent reduced risk of death and a 64 percent reduced risk of hospitalization for influenza or pneumonia compared with those who receive a standard-dose vaccine, results of the DANFLU-1 study showed.

22 Sep 2022

Continuous repeated guidance improves inhaler device use in older adults

22 Sep 2022 by

Older adults who receive continued repeated guidance show fewer errors in inhaler use, according to a recent study.

22 Sep 2022

Inhaled IFN-β1a shows favourable signals for hospitalized COVID-19 patients

22 Sep 2022 by

In the phase III SPRINTER trial, inhaled interferon-beta-1a (IFN-β1a) showed encouraging signals for preventing disease progression or death in hospitalized COVID-19 patients.

22 Sep 2022

Tezepelumab reduces mucus plugging in patients with asthma

22 Sep 2022 by

In patients with uncontrolled, moderate-to-severe asthma, tezepelumab reduced mucus plugging, which was also tied to improvements in lung function parameters, according to an exploratory post hoc analysis of the CASCADE* trial presented at ERS 2022.

22 Sep 2022

Antibiotics for COPD exacerbations: Aye or nay?

21 Sep 2022 by

Antibiotics cannot be withheld in patients with chronic obstructive pulmonary disease (COPD) seeking treatment for acute moderate exacerbations, suggests findings from the ABACOPD study presented at ERS 2022. However, in one subgroup, it appeared antibiotics can be ruled out.

21 Sep 2022

Remote smoking cessation programme delivers encouraging results in high-risk individuals

20 Sep 2022 by

A smoking cessation intervention delivered via telephone resulted in greater smoking cessation rates than usual care among individuals enrolled in targeted lung health screening, according to results of the QuLIT*2 study from the UK presented at ERS 2022.

20 Sep 2022

Pirfenidone may benefit RA-ILD patients

20 Sep 2022 by

In the phase II TRAIL1 trial, oral pirfenidone slowed the rate of decline in lung function in individuals with rheumatoid arthritis-associated interstitial lung disease (RA-ILD).

20 Sep 2022

Severe OSA doubles the risk of unprovoked VTE

20 Sep 2022 by

Patients with obstructive sleep apnoea (OSA) who had the longest nocturnal hypoxaemia episodes have a twofold risk of developing venous thromboembolic events (VTE) in a study dubbed as the first to investigate the association between OSA and the incidence of unprovoked VTE.

20 Sep 2022

News & Updates

Showing Respirology articles

Showing

Specialty:

Sotrovimab of no help in attenuating COVID-19 severity in face of Omicron BA.2 subvariant

Play-based exercise boosts fitness, fundamental movement in kids with bronchiectasis

DANFLU-1: High-dose quadrivalent flu vax reduces hospitalization, death in older adults

Continuous repeated guidance improves inhaler device use in older adults

Inhaled IFN-β1a shows favourable signals for hospitalized COVID-19 patients

Tezepelumab reduces mucus plugging in patients with asthma

Antibiotics for COPD exacerbations: Aye or nay?

Remote smoking cessation programme delivers encouraging results in high-risk individuals

Pirfenidone may benefit RA-ILD patients

Severe OSA doubles the risk of unprovoked VTE